Cargando…

Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome

CONTEXT: Hyperandrogenism is a central feature of polycystic ovary syndrome (PCOS). In vitro studies have demonstrated that inflammatory stimuli promote whereas ibuprofen inhibits androgen production by ovarian theca-interstitial cells. OBJECTIVE: This work aimed to determine the effects of nonselec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banaszewska, Beata, Ozegowska, Katarzyna, Polska, Martyna, Pawelczyk, Leszek, Chang, R Jeffrey, Duleba, Antoni J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508875/ https://www.ncbi.nlm.nih.gov/pubmed/36168587 http://dx.doi.org/10.1210/jendso/bvac128

Ejemplares similares

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome
por: Homer, Michael V, et al.
Publicado: (2019)

Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
por: Karakas, Sidika E., et al.
Publicado: (2010)

Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome
por: Dumesic, Daniel A, et al.
Publicado: (2023)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
por: Dumesic, Daniel A, et al.
Publicado: (2021)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Serum Metabolomics in PCOS Women with Different Body Mass Index
por: Ożegowska, Katarzyna, et al.
Publicado: (2021)

Serum Leptin Level in Women with Polycystic Ovary Syndrome: Correlation with Adiposity, Insulin, and Circulating Testosterone
por: Chakrabarti, J
Publicado: (2013)

Circulating SCUBE1 levels in women with polycystic ovary syndrome
por: Erol, Onur, et al.
Publicado: (2018)

Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis
por: Hao, Song-Li, et al.
Publicado: (2023)

The Relation Between Free Testosterone and Components of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
por: Abbasi-Ranjbar, Zahra, et al.
Publicado: (2018)

Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
por: Adamczak, Agnieszka, et al.
Publicado: (2023)

Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome
por: Montezuma, Thais, et al.
Publicado: (2011)

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
por: Acmaz, G., et al.
Publicado: (2019)

Peripheral hematological parameters in women with polycystic ovary syndrome
por: ALhabardi, Nadiah A, et al.
Publicado: (2020)

Retinal Nerve Fiber Layer Thickness in Women with Polycystic Ovary Syndrome
por: Demir, Mehmet, et al.
Publicado: (2013)

Resveratrol Is Not as Effective as Physical Exercise for Improving Reproductive and Metabolic Functions in Rats with Dihydrotestosterone-Induced Polycystic Ovary Syndrome
por: Benrick, Anna, et al.
Publicado: (2013)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
por: Hernández-Yero, Arturo, et al.
Publicado: (2012)

Laparoscopic Ovarian Drilling Reduces Testosterone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio and Improves Clinical Outcome in Women with Polycystic Ovary Syndrome
por: Sinha, Priyanka, et al.
Publicado: (2019)

Can Psychosocial Intervention Suppress Testosterone and Triglycerides Among Women With Polycystic Ovary Syndrome? A Feasibility Trial
por: Yin, Margaret X. C., et al.
Publicado: (2021)

Effects of high-intensity interval training and strength training on levels of testosterone and physical activity among women with polycystic ovary syndrome
por: Rao, Mubarra, et al.
Publicado: (2022)

Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
por: Paalanne, Marika, et al.
Publicado: (2021)

Coronary artery disease risk in young women with polycystic ovary syndrome
por: Ding, Dah-Ching, et al.
Publicado: (2018)

Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome
por: Stokkeland, Live Marie T, et al.
Publicado: (2021)

The relationship between Polycystic ovary syndrome and vitamin D levels
por: Yılmaz, Setenay Arzu, et al.
Publicado: (2015)

Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea
por: Abbara, Ali, et al.
Publicado: (2023)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Polycystic ovary syndrome induced by exposure to testosterone propionate and effects of sympathectomy on the persistence of the syndrome
por: Morales-Ledesma, Leticia, et al.
Publicado: (2017)

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
por: Głuszak, Olgierd, et al.
Publicado: (2012)

Predictors of pregnancy after intrauterine insemination in women with polycystic ovary syndrome
por: Guan, Hui-Juan, et al.
Publicado: (2021)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Lower sexual satisfaction in women with polycystic ovary syndrome and metabolic syndrome
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome
por: Wide, Leif, et al.
Publicado: (2021)

The relationships of sex hormone‐binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials
por: Almalki, Hussain H., et al.
Publicado: (2020)

Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation
por: Wyskida, Katarzyna, et al.
Publicado: (2020)

Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women
por: Kargili, Ayse, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cpcv4ggggc2vmmttgtp59k0qll